New insights into thyroid hormone actions and lipid metabolism

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 5, 2010, Pages 395-

  Davis, Paul ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; INTEGRIN; PROPIONIC ACID; THYROID HORMONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; BODY FAT DISTRIBUTION; EDITORIAL; FATTY LIVER; HUMAN; HYPERPARATHYROIDISM; LIPID METABOLISM; MITOCHONDRION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; FATTY LIVER; HUMANS; HYPERLIPIDEMIAS; HYPERTHYROIDISM; LIPID METABOLISM; OBESITY; RATS; THYROID HORMONES;

EID: 77956232548     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833e2f0f     Document Type: Editorial

References (9)

1. Scanlan TS. Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart Fail Rev 2010; 15:177-182.
2. Villicev CM, Freitas FR, Aoki MS, et al. Thyroid hormone receptor b-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. J Endocrinol 2007; 193:21-29.
3. Ocasio CA, Scanlan TS. Design and characterization of a thyroid hormone receptor a (TRa)-specific agonist. ACS Chem Biol 2006; 1:585-593.
4. Ocasio CA, Scanlan TS. Characterization of thyroid hormone receptor a (TRa)-specific analogs with varying inner-and outer-ring substituents. Biorg Med Chem 2008; 16:762-770.
5. Morkin E, Ladenson P, Goldman S, Adamson C. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol 2004; 37:1137-1146.
6. Ladenson PW, McCarren M, Morkin E, et al. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. J Clin Endo-crinol Metab 2010; 95:1349-1354.
7. Mousa SA, O'Connor LJ, Davis FB, Davis PJ. Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 2006; 147:1602-1607.
8. Davis PJ, Davis FB, Lin HY, et al. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 2009; 297:E1238-E1246.
9. Lanni A, Moreno M, Lombardi A. A 3, 5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J 2005; 19:1552-1554.